Effect of Pneumococcal Vaccination in Hospitalized Adults With Community-Acquired Pneumonia | Zendy

Jennie Johnstone | Zendy; Thomas J. Marrie | Zendy; Dean T. Eurich | Zendy; Sumit R. Majumdar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Pneumococcal Vaccination in Hospitalized Adults With Community-Acquired Pneumonia

Author(s) -

Jennie Johnstone,

Thomas J. Marrie,

Dean T. Eurich,

Sumit R. Majumdar

Publication year - 2007

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.167.18.1938

Subject(s) - medicine , pneumonia , community acquired pneumonia , odds ratio , propensity score matching , intensive care unit , confidence interval , pneumococcal polysaccharide vaccine , vaccination , population , pneumococcal vaccine , pneumococcal pneumonia , pediatrics , streptococcus pneumoniae , pneumococcal disease , immunology , environmental health , biology , bacteria , genetics

Although 23-valent polysaccharide pneumococcal vaccine (PPV) does not prevent community-acquired pneumonia (CAP), it might still improve outcomes in those who develop pneumonia. We tested this hypothesis using a population-based cohort of hospitalized patients with CAP.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research